ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,523.79
      1.04%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. BiondVax Pharmaceuticals Ltd (BVXV)

      7. BiondVax Pharmaceuticals Ltd (BVXV) News

      BVXV

      BiondVax Pharmaceuticals (BVXV)

      BiondVax Pharmaceuticals Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BVXV
      DateTimeSourceHeadlineSymbolCompany
      06/12/20208:04AMEdgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/12/20208:00AMPR Newswire (US)BiondVax Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Business UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/10/20207:48AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      06/10/20207:00AMPR Newswire (US)NIH Report on Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Concludes Both Primary Endpoin...NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/20/20207:44AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/20/20206:30AMPR Newswire (US)BiondVax Announces Receipt of $4.2 Million Through Exercise of WarrantsNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/13/20204:34PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/04/202010:48AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      05/04/20206:30AMPR Newswire (US)BiondVax Announces Upcoming Expiration of Public WarrantsNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      04/30/20209:40AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/24/20204:28PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/24/20204:01PMPR Newswire (US)New Directors Elected to BiondVax's Board of DirectorsNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/19/20201:06PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      03/19/20207:15AMPR Newswire (US)BiondVax's CEO Comments on Impact of COVID-19 Pandemic on the Company's Ongoing Phase 3 Clinical TrialNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/25/202012:42PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/10/20205:22PMEdgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/10/202011:15AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/05/20203:25PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      02/05/20201:00PMPR Newswire (US)Preliminary Data from NIH/NIAID-sponsored Phase 2 Clinical Trial of BiondVax's M-001 Universal Influenza Vaccine Candidate Va...NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      01/24/20204:16PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      01/16/20203:08PMPR Newswire (US)BiondVax Announces Warrant Agreement Amendment to Permit Holders of Warrants to Exercise Both on a Cash and Cashless BasisNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      01/16/20202:47PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      01/16/20209:28AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      01/14/20206:01AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      01/13/20206:25AMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      01/07/202010:51AMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      12/31/20192:13PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/26/20192:19PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/26/20197:00AMPR Newswire (US)BiondVax Announces Third Quarter 2019 Financial Results and Business UpdateNASDAQ:BVXVBiondVax Pharmaceuticals Ltd
      11/18/20191:26PMEdgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:BVXVBiondVax Pharmaceuticals Ltd
       Showing the most relevant articles for your search:NASDAQ:BVXV